IRESSA Side Effects

6930105-2 | Recurring Skin Boils
on Jan 11, 2010 Male patient from UNITED STATES , 58 years of age, was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: recurring skin boils. Iressa dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6930103-9 | Dry Skin, Rash, Rhinorrhoea
Patient was taking Iressa (View Usage). Patient had the following side effects: dry skin, rash (What is rash?), rhinorrhoea on Sep 10, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 175.0 lb, . Iressa dosage: . During the same period patient was treated with GABAPENTIN (View Gabapentin Review and Gabapentin Label ), ZETIA (View Zetia Review and Zetia Label ), GEMFIBROZOLE (View Gemfibrozole Review and Gemfibrozole Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), OMNEPROZOLE (View Omneprozole Review and Omneprozole Label ), ZOTREL (View Zotrel Review and Zotrel Label ), FERRUS SULFATE (View Ferrus Sulfate Review and Ferrus Sulfate Label ).

6930102-7 | Alopecia, Diarrhoea, Hair Texture Abnormal
Adverse event was reported on Nov 03, 2009 by a Female patient taking Iressa (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 117.1 lb, After Iressa was administered, patient had the following side effects: alopecia, diarrhoea, hair texture abnormal.

6930096-4 | Bronchioloalveolar Carcinoma
on Mar 10, 2010 Female patient from UNITED STATES , 63 years of age, was diagnosed with bronchioloalveolar carcinoma and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: bronchioloalveolar carcinoma. Iressa dosage: .


6928272-X | Gastrointestinal Perforation
on Aug 10, 2010 Male patient from JAPAN , 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). Patient had the following side effects: gastrointestinal perforation. Iressa dosage: . Patient was hospitalized.

6925092-7 | Retinal Disorder
Patient was taking Iressa (View Usage). After Iressa was administered, patient had the following side effects: retinal disorder (What is retinal disorder?) on Aug 05, 2010 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with non-small cell lung cancer and. Iressa dosage: .

6924857-5 | Dermatitis Acneiform, Henoch-schonlein Purpura
Adverse event was reported on Aug 09, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: JAPAN , 52 years of age, weighting 108.0 lb, Patient experienced the following unwanted or unexpected effects: dermatitis acneiform, henoch-schonlein purpura. Patient was hospitalized.

6923120-6 | Ileal Perforation
on Aug 04, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). Patient had the following side effects: ileal perforation. Iressa dosage: .

6922900-0 | Impetigo
on Aug 04, 2010 Female patient from JAPAN , 84 years of age, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: impetigo (What is impetigo?). Iressa dosage: . Patient was hospitalized.

6920863-5 | Dehydration, Diarrhoea, Renal Impairment
Patient was taking Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, renal impairment on Aug 03, 2010 from JAPAN Additional patient health information: Female patient , 70 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer and. Iressa dosage: . During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), DECADRON (View Decadron Review and Decadron Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), LAC B (View Lac-b Review and Lac-b Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6910544-6 | Lung Disorder
Adverse event was reported on Aug 02, 2010 by a Male patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung neoplasm malignant and. Location: JAPAN , 68 years of age, weighting 149.9 lb, Patient had the following side effects: lung disorder. During the same period patient was treated with PYRINAZIN (View Pyrinazin Review and Pyrinazin Label ), GRIMAC (View Grimac Review and Grimac Label ), GASPORT D (View Gasport-d Review and Gasport-d Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), MODACIN (View Modacin Review and Modacin Label ).

6910281-8 | Neutrophil Count Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
on Jul 28, 2010 Male patient from JAPAN , 89 years of age, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: neutrophil count decreased, platelet count decreased, white blood cell count decreased. Iressa dosage: .

6907867-3 | Liver Disorder
on Jul 27, 2010 Male patient from JAPAN , 60 years of age, was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Iressa dosage: . Patient was hospitalized.

6907699-6 | Liver Disorder
Patient was taking Iressa (View Usage). Patient had the following side effects: liver disorder on Jul 27, 2010 from JAPAN Additional patient health information: Female patient , 69 years of age, was diagnosed with lung adenocarcinoma and. Iressa dosage: .

6907697-2 | Dyspnoea, Haemorrhage Subcutaneous, Interstitial Lung Disease
Adverse event was reported on Jul 27, 2010 by a Male patient taking Iressa (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: CHINA , weighting 143.3 lb, After Iressa was administered, patient had the following side effects: dyspnoea, haemorrhage subcutaneous, interstitial lung disease. Patient was hospitalized.

6900514-6 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Hepatic Function Abnormal
on Jul 27, 2010 Male patient from JAPAN , 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal. Iressa dosage: .

6900246-4 | Hepatic Function Abnormal
on Jul 27, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). Patient had the following side effects: hepatic function abnormal. Iressa dosage: .

6900160-4 | Hepatic Function Abnormal
Patient was taking Iressa (View Usage). After Iressa was administered, patient had the following side effects: hepatic function abnormal on Jul 27, 2010 from JAPAN Additional patient health information: Male patient , 55 years of age, was diagnosed with lung adenocarcinoma and. Iressa dosage: .

6900105-7 | Lung Disorder
Adverse event was reported on Jul 30, 2010 by a Male patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung neoplasm malignant and. Location: JAPAN , 68 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: lung disorder. During the same period patient was treated with PYRINAZIN (View Pyrinazin Review and Pyrinazin Label ), GRIMAC (View Grimac Review and Grimac Label ), GASPORT D (View Gasport-d Review and Gasport-d Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), MODACIN (View Modacin Review and Modacin Label ).

6900097-0 | Hepatic Function Abnormal
on Jul 27, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). Patient had the following side effects: hepatic function abnormal. Iressa dosage: .

6899878-1 | Hepatic Function Abnormal
on Jul 27, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: hepatic function abnormal. Iressa dosage: .

6899819-7 | Hepatic Function Abnormal
Patient was taking Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal on Jul 27, 2010 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with lung adenocarcinoma and. Iressa dosage: .

6899818-5 | Hepatic Function Abnormal
Adverse event was reported on Jul 27, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma and. Location: JAPAN , 61 years of age, Patient had the following side effects: hepatic function abnormal.

6899808-2 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Hepatic Function Abnormal, Liver Injury
on Jul 27, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal, liver injury. Iressa dosage: .

6886975-X | Neutrophil Count Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
on Jul 21, 2010 Male patient from JAPAN , 89 years of age, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: neutrophil count decreased, platelet count decreased, white blood cell count decreased. Iressa dosage: .

6882496-9 | Cerebral Thrombosis
Patient was taking Iressa (View Usage). Patient had the following side effects: cerebral thrombosis on Jul 23, 2010 from CHINA Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with non-small cell lung cancer and. Iressa dosage: . Patient was hospitalized.

6882493-3 | Confusional State, Diarrhoea, Pseudodementia
Adverse event was reported on Jul 19, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung cancer metastatic, pain (What is pain?), prophylaxis against gastrointestinal ulcer, thrombosis prophylaxis and. Location: FRANCE , weighting 121.3 lb, After Iressa was administered, patient had the following side effects: confusional state, diarrhoea, pseudodementia. During the same period patient was treated with DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), NEXIUM (View Nexium Review and Nexium Label ), LOVENOX (View Lovenox Review and Lovenox Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6882159-X | Cystitis Bacterial, Diarrhoea, Skin Disorder
on Jul 21, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis bacterial, diarrhoea, skin disorder. Iressa dosage: .

6879895-8 | Haemorrhage Subcutaneous
on Jul 21, 2010 Male patient from CHINA , weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). Patient had the following side effects: haemorrhage subcutaneous. Iressa dosage: . Patient was hospitalized.

6879825-9 | Purpura
Patient was taking Iressa (View Usage). After Iressa was administered, patient had the following side effects: purpura on Jul 21, 2010 from JAPAN Additional patient health information: Female patient , 74 years of age, was diagnosed with non-small cell lung cancer and. Iressa dosage: . During the same period patient was treated with FUNGIZONE (4 Ml/day) (View Fungizone Review and Fungizone Label ), DECADRON (8 Df/day) (View Decadron Review and Decadron Label ).

6876948-5 | Dysphagia, Oropharyngeal Blistering, Rash Pruritic
Adverse event was reported on Jul 15, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: CHINA , 52 years of age, Patient experienced the following unwanted or unexpected effects: dysphagia, oropharyngeal blistering, rash pruritic. Patient was hospitalized.

6875629-1 | Nausea, Neuralgia
on Jul 13, 2010 Female patient from AUSTRALIA , 82 years of age, was treated with Iressa (View Usage). Patient had the following side effects: nausea (What is nausea?), neuralgia. Iressa dosage: . Patient was hospitalized and became disabled.

6866130-X | Respiratory Disorder
on Jul 13, 2010 Female patient from MEXICO , 37 years of age, weighting 70.11 lb, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: respiratory disorder. Iressa dosage: . Patient was hospitalized.

6866113-X | Cardiac Failure, Pleural Effusion
Patient was taking Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, pleural effusion on Jul 13, 2010 from MEXICO Additional patient health information: Female patient , 86 years of age, . Iressa dosage: . Patient was hospitalized.

6847430-6 | Nausea, Neuralgia
Adverse event was reported on Jul 13, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) . Location: AUSTRALIA , 82 years of age, Patient had the following side effects: nausea (What is nausea?), neuralgia. Patient was hospitalized and became disabled.

6847417-3 | Dysphagia, Oropharyngeal Blistering, Rash Pruritic
on Jul 08, 2010 Female patient from CHINA , 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: dysphagia, oropharyngeal blistering, rash pruritic. Iressa dosage: . Patient was hospitalized.

6847392-1 | Diarrhoea Haemorrhagic, Loss Of Consciousness, Sepsis, Urinary Tract Infection
on Jul 07, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 86 years of age, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea haemorrhagic, loss of consciousness, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?). Iressa dosage: . Patient was hospitalized.

6843430-0 | Interstitial Lung Disease, Liver Injury, Lung Infection, Multi-organ Failure
Patient was taking Iressa (View Usage). Patient had the following side effects: interstitial lung disease, liver injury, lung infection, multi-organ failure on Jul 12, 2010 from CHINA Additional patient health information: Male patient , 65 years of age, was diagnosed with non-small cell lung cancer and. Iressa dosage: . During the same period patient was treated with PLENDIL (View Plendil Review and Plendil Label ), LOTENSIN (View Lotensin Review and Lotensin Label ), PROSCAR (View Proscar Review and Proscar Label ).

6832248-0 | Cardiac Output Decreased, Pleural Effusion
Adverse event was reported on Jul 01, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) . Location: MEXICO , 86 years of age, After Iressa was administered, patient had the following side effects: cardiac output decreased, pleural effusion. Patient was hospitalized.

6831710-4 | Keratitis
on Jul 02, 2010 Male patient from JAPAN , 78 years of age, weighting 154.3 lb, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: keratitis. Iressa dosage: .

6831203-4 | Rash, Skin Ulcer
on Jul 02, 2010 Female patient from JAPAN , weighting 77.16 lb, was diagnosed with lung adenocarcinoma, rash (What is rash?), back pain (What is back pain?), gastric ulcer and was treated with Iressa (View Usage). Patient had the following side effects: rash (What is rash?), skin ulcer. Iressa dosage: . During the same period patient was treated with ALMETA (Optimal Dose, Daily.) (View Almeta Review and Almeta Label ), HYPEN (View Hypen Review and Hypen Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MILTAX (View Miltax Review and Miltax Label ), HIRUDOID (View Hirudoid Review and Hirudoid Label ). Patient was hospitalized and became disabled.

6830817-5 | Interstitial Lung Disease, Liver Injury, Multi-organ Failure
Patient was taking Iressa (View Usage). After Iressa was administered, patient had the following side effects: interstitial lung disease, liver injury, multi-organ failure on Jul 07, 2010 from CHINA Additional patient health information: Male patient , 65 years of age, was diagnosed with non-small cell lung cancer and. Iressa dosage: .

6826358-1 | Liver Disorder
Adverse event was reported on Jul 01, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma, nasopharyngitis and. Location: JAPAN , weighting 108.0 lb, Patient experienced the following unwanted or unexpected effects: liver disorder. During the same period patient was treated with FLOMOX (View Flomox Review and Flomox Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

6826104-1 | Muscular Weakness
on Jun 30, 2010 Female patient from KOREA, REPUBLIC OF , weighting 103.6 lb, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). Patient had the following side effects: muscular weakness. Iressa dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6822330-6 | Cerebral Infarction
on Jun 29, 2010 Female patient from JAPAN , 75 years of age, weighting 88.18 lb, was diagnosed with non-small cell lung cancer, hyperlipidaemia, hypertension, prophylaxis of nausea and vomiting and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: cerebral infarction. Iressa dosage: . During the same period patient was treated with PARAPLATIN (View Paraplatin Review and Paraplatin Label ), ALIMTA (View Alimta Review and Alimta Label ), CRESTOR (View Crestor Review and Crestor Label ), TOWARAT CR (View Towarat-cr Review and Towarat-cr Label ), PANVITAN (View Panvitan Review and Panvitan Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ), KYTRIL (View Kytril Review and Kytril Label ), DECADRON (View Decadron Review and Decadron Label ).

6820096-7 | Retinal Disorder
Patient was taking Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: retinal disorder (What is retinal disorder?) on Jun 29, 2010 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with non-small cell lung cancer and. Iressa dosage: .

6814559-8 | Hepatic Function Abnormal
Adverse event was reported on Jun 23, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung neoplasm malignant and. Location: JAPAN , 60 years of age, Patient had the following side effects: hepatic function abnormal.

6813998-9 | Rash, Skin Ulcer
on Jun 24, 2010 Female patient from JAPAN , weighting 77.16 lb, was diagnosed with lung adenocarcinoma, rash (What is rash?), back pain (What is back pain?), gastric ulcer and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: rash (What is rash?), skin ulcer. Iressa dosage: . During the same period patient was treated with ALMETA (Optimal Dose Every Day.) (View Almeta Review and Almeta Label ), HYPEN (View Hypen Review and Hypen Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MILTAX (View Miltax Review and Miltax Label ), HIRUDOID (View Hirudoid Review and Hirudoid Label ). Patient was hospitalized and became disabled.

6812166-4 | Dementia, Diarrhoea
on Jun 22, 2010 Female patient from FRANCE , 75 years of age, was diagnosed with lung neoplasm malignant and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?), diarrhoea. Iressa dosage: . Patient was hospitalized.

6812024-5 | Pneumonia
Patient was taking Iressa (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?) on Jun 22, 2010 from JAPAN Additional patient health information: Female patient , 80 years of age, was diagnosed with lung neoplasm malignant and. Iressa dosage: . Patient was hospitalized.